1.Propacetamol as an alternative of ketorolac for postoperative pain management using patient-controlled analgesia.
Sang Gyun KIM ; Jihyun AN ; Ji Hyang LEE ; Eunju KIM ; Sang Gon LEE ; Kwangsuk SIM
Anesthesia and Pain Medicine 2017;12(4):326-334
BACKGROUND: The objective of this study was to examine effect of propacetamol in comparison with ketorolac in intravenous patient-controlled analgesia after gynecologic surgeries. METHODS: Patients aged 18 to 70 years and undergoing laparoscopic gynecologic surgeries were selected. They were randomly allocated to either group K (180 mg of ketorolac with fentanyl and ramosetron) or group P (10 g of propacetamol with fentanyl and ramosetron). Their vital signs and visual analogue scale (VAS) were examined six times (0 min, 15 min, 30 min, 60 min, 12 h, and 24 h) and laboratory workup was done 48 hours after PCA application. Development of side effects was examined 15 minutes after the PCA application. Data from 111 patients were used for the final analysis. RESULTS: There were no significant differences in changes of systolic and diastolic blood pressures, heart rate, body temperature, and VAS between the groups (P = 0.325, 0.835, 0.346, 0.524, and 0.382, respectively). There were significant differences in the levels of hemoglobin, hematocrit, blood urea nitrogen, and international normalized ratio but it was not clinically meaningful. The development of vomiting, dizziness, and headache were not significantly different between the groups and no patient developed pruritus. Although the overall number of patients with nausea was higher in group P with statistical significance (P = 0.002), there were no significant differences between the groups when examined at each detection time. CONCLUSIONS: The present study suggested propacetamol as a possible alternative of ketorolac in postoperative care after laparoscopic gynecologic surgeries.
Analgesia
;
Analgesia, Patient-Controlled*
;
Blood Urea Nitrogen
;
Body Temperature
;
Dizziness
;
Female
;
Fentanyl
;
Gynecologic Surgical Procedures
;
Headache
;
Heart Rate
;
Hematocrit
;
Humans
;
International Normalized Ratio
;
Ketorolac*
;
Nausea
;
Pain, Postoperative*
;
Passive Cutaneous Anaphylaxis
;
Postoperative Care
;
Pruritus
;
Vital Signs
;
Vomiting
2.Propacetamol as an alternative of ketorolac for postoperative pain management using patient-controlled analgesia.
Sang Gyun KIM ; Jihyun AN ; Ji Hyang LEE ; Eunju KIM ; Sang Gon LEE ; Kwangsuk SIM
Anesthesia and Pain Medicine 2017;12(4):326-334
BACKGROUND: The objective of this study was to examine effect of propacetamol in comparison with ketorolac in intravenous patient-controlled analgesia after gynecologic surgeries. METHODS: Patients aged 18 to 70 years and undergoing laparoscopic gynecologic surgeries were selected. They were randomly allocated to either group K (180 mg of ketorolac with fentanyl and ramosetron) or group P (10 g of propacetamol with fentanyl and ramosetron). Their vital signs and visual analogue scale (VAS) were examined six times (0 min, 15 min, 30 min, 60 min, 12 h, and 24 h) and laboratory workup was done 48 hours after PCA application. Development of side effects was examined 15 minutes after the PCA application. Data from 111 patients were used for the final analysis. RESULTS: There were no significant differences in changes of systolic and diastolic blood pressures, heart rate, body temperature, and VAS between the groups (P = 0.325, 0.835, 0.346, 0.524, and 0.382, respectively). There were significant differences in the levels of hemoglobin, hematocrit, blood urea nitrogen, and international normalized ratio but it was not clinically meaningful. The development of vomiting, dizziness, and headache were not significantly different between the groups and no patient developed pruritus. Although the overall number of patients with nausea was higher in group P with statistical significance (P = 0.002), there were no significant differences between the groups when examined at each detection time. CONCLUSIONS: The present study suggested propacetamol as a possible alternative of ketorolac in postoperative care after laparoscopic gynecologic surgeries.
Analgesia
;
Analgesia, Patient-Controlled*
;
Blood Urea Nitrogen
;
Body Temperature
;
Dizziness
;
Female
;
Fentanyl
;
Gynecologic Surgical Procedures
;
Headache
;
Heart Rate
;
Hematocrit
;
Humans
;
International Normalized Ratio
;
Ketorolac*
;
Nausea
;
Pain, Postoperative*
;
Passive Cutaneous Anaphylaxis
;
Postoperative Care
;
Pruritus
;
Vital Signs
;
Vomiting
3.Incidence and Risk Factors of Rehospitalization with Respiratory Syncytial Virus Infection in Premature Infants.
Eun Ah LEE ; Jea Heon JEONG ; Seung Taek YU ; Chang Woo LEE ; Hyang Suk YOON ; Do Sim PARK ; Yeon Kyun OH
Korean Journal of Pediatrics 2004;47(5):510-514
PURPOSE: We performed this study to evaluate the risk of rehospitalization for respiratory syncytial virus(RSV) infection among premature infants discharged from a neonatal intensive care unit(NICU). METHODS: We performed a retrospective study for rehospitalization for RSV infection and risk factors among premature infants who were admitted to NICU and discharged between May 2001 and April 2003 in Wonkwang University Hospital. RSV detection was utilized by direct fluorescent antibody tests in nasopharyngeal aspirates. We also reviewed various risk factors including gestational age, birth weight, sex, ventilatory care, surfactant administration, chronic lung disease(CLD), siblings in school or kindergarten age, and month of discharge. RESULTS: The rehospitalization rate for RSV infection was 6.6%(26/381) in premature infants and 22.2%(4/18) in premature infants with CLD. The most common season of rehospitalization for RSV infection was between November to January, this was 69.2%(18/26) in premature infants, the same as children: 61.2%(93/152). The risk factors for RSV rehospitalization among premature infants were CLD, siblings in school or kindergarten age and discharge between October to December from NICU. CONCLUSION: The risk for RSV rehospitalization among premature infants from NICU was low. Preterm infants subject to risk factors of CLD, siblings in school or kindergarten age, and discharge between October to December from NICU, were most likely to require hospitalization for RSV disease. In CONCLUSION: Prophylaxis for RSV infection should be considered one month before discharge from NICU in the RSV season between October and December.
Birth Weight
;
Child
;
Gestational Age
;
Hospitalization
;
Humans
;
Incidence*
;
Infant, Newborn
;
Infant, Premature*
;
Intensive Care, Neonatal
;
Lung
;
Respiratory Syncytial Viruses*
;
Retrospective Studies
;
Risk Factors*
;
Seasons
;
Siblings
4.Treatment of Hidradenitis Suppurativa Patient with Klinefelter Syndrome by Adalimumab
Ji Yeoun SHIN ; Jung Yeon HONG ; Ho Jung LEE ; Chang Yoon SIM ; Young Lip PARK ; Jong Suk LEE ; Sung Yul LEE ; Jung Eun KIM
Annals of Dermatology 2019;31(4):446-449
Hidradenitis suppurativa (HS) is a chronic, inflammatory and painful skin disease with recurrent nodules and tracts involving the intertriginous regions. It is known that the patient with HS shows an increased risk of metabolic disorders such as diabetes, metabolic syndrome and autoimmune diseases. Klinefelter syndrome (KS) is a sex chromosomal disorder occurring in males due to an abnormality of sexual differentiation, characterized by 47, XXY karyotype. Also, KS is related with somatic comorbidities such as metabolic syndrome, autoimmune and rheumatologic disorders as HS is. We report a HS patient with KS who shows a big improvement while on tumor necrosis factor-alpha inhibitor treatment.
Adalimumab
;
Autoimmune Diseases
;
Chromosome Disorders
;
Comorbidity
;
Hidradenitis Suppurativa
;
Hidradenitis
;
Humans
;
Karyotype
;
Klinefelter Syndrome
;
Male
;
Sex Differentiation
;
Skin Diseases
;
Tumor Necrosis Factor-alpha
5.Overlapped multiple distal entrapment neuropathies hindering diagnosis of thoracic outlet syndrome: A case report.
Ji Hye SEOK ; Jun Ho LEE ; Kwang Seok SIM ; Jong Seok BAN ; Ji Hyang LEE ; Eun Ju KIM
Anesthesia and Pain Medicine 2012;7(4):348-351
Thoracic outlet syndrome is caused by the compression of neurovascular structures at the thoracic outlet region. Diagnosis is difficult since thoracic outlet syndrome is often accompanied by distal entrapment neuropathies such as carpal tunnel syndrome or ulnar and radial neuropathies. In this article, the authors report a case regarding a patient with thoracic outlet syndrome whose diagnosis was delayed due to the overlapping of multiple distal entrapment neuropathies.
Carpal Tunnel Syndrome
;
Humans
;
Nerve Compression Syndromes
;
Radial Neuropathy
;
Thoracic Outlet Syndrome
6.Strategy for Novel Vaccine and Antivirals Against Foot-and-Mouth Disease.
Jong Hyeon PARK ; Su Mi KIM ; Kwang Nyeong LEE ; Young Joon KO ; Hyang Sim LEE ; In Soo CHO
Journal of Bacteriology and Virology 2010;40(1):1-10
Foot-and-mouth disease (FMD) is a highly contagious, virally induced disease of cloven-hoofed animals. FMD-affected countries have suffered from a serious economic impact due to their decreased participation in the international livestock trade. Currently, disease control measures include inhibition of susceptible animal movement, slaughter of infected and susceptible in-contact animals, disinfection, and vaccination with an inactivated whole virus antigen. Researchers have attempted to develop new FMD vaccines to overcome the limitations of the current inactivated vaccine as well as new antivirals to more rapidly induce a protective response. In this study, we discuss the most effective novel FMD vaccines and antiviral strategies that are currently being studied. The vaccine research using subunits, synthetic peptides, DNA, cytokine-enhanced DNA, recombinant empty capsids, chimeric viruses, genetically engineered attenuated viruses, recombinant viral vectors, self-replicating DNA and transgenic plants expressing virus proteins is part of a trend towards novel FMD vaccine development. The antiviral methods using RNA interference (RNAi), RNAi-based recombinant adenoviruses and L(pro) or 3D(pol) inhibitors represent the current replication-inhibiting medicine used to control FMD.
Adenoviridae
;
Animals
;
Antiviral Agents
;
Capsid
;
Disinfection
;
DNA
;
DNA, Recombinant
;
Foot-and-Mouth Disease
;
Livestock
;
Peptides
;
Plants, Genetically Modified
;
Proteins
;
RNA Interference
;
Vaccination
;
Vaccines
;
Viruses
7.Strategy for Novel Vaccine and Antivirals Against Foot-and-Mouth Disease.
Jong Hyeon PARK ; Su Mi KIM ; Kwang Nyeong LEE ; Young Joon KO ; Hyang Sim LEE ; In Soo CHO
Journal of Bacteriology and Virology 2010;40(1):1-10
Foot-and-mouth disease (FMD) is a highly contagious, virally induced disease of cloven-hoofed animals. FMD-affected countries have suffered from a serious economic impact due to their decreased participation in the international livestock trade. Currently, disease control measures include inhibition of susceptible animal movement, slaughter of infected and susceptible in-contact animals, disinfection, and vaccination with an inactivated whole virus antigen. Researchers have attempted to develop new FMD vaccines to overcome the limitations of the current inactivated vaccine as well as new antivirals to more rapidly induce a protective response. In this study, we discuss the most effective novel FMD vaccines and antiviral strategies that are currently being studied. The vaccine research using subunits, synthetic peptides, DNA, cytokine-enhanced DNA, recombinant empty capsids, chimeric viruses, genetically engineered attenuated viruses, recombinant viral vectors, self-replicating DNA and transgenic plants expressing virus proteins is part of a trend towards novel FMD vaccine development. The antiviral methods using RNA interference (RNAi), RNAi-based recombinant adenoviruses and L(pro) or 3D(pol) inhibitors represent the current replication-inhibiting medicine used to control FMD.
Adenoviridae
;
Animals
;
Antiviral Agents
;
Capsid
;
Disinfection
;
DNA
;
DNA, Recombinant
;
Foot-and-Mouth Disease
;
Livestock
;
Peptides
;
Plants, Genetically Modified
;
Proteins
;
RNA Interference
;
Vaccination
;
Vaccines
;
Viruses
8.Human Adenovirus Type 5 as a Delivery Vector is Not Neutralized in Field Serum Samples of Cattle, Pig, and Goat of Republic of Korea.
Su Mi KIM ; Hyang Sim LEE ; Kwang Nyeong LEE ; Jong Hyeon PARK ; Young Joon KO ; Byounghan KIM
Journal of Bacteriology and Virology 2014;44(3):269-273
Human adenovirus type 5 (hAd5) vectors have been demonstrated to be useful vehicles for gene expressions in animals. However, it has not been reported whether hAd5 transduction might be hampered in the sera of livestock animals in Republic of Korea. We collected 205 samples of livestock animals, such as pig (n=84), cattle (n=84), and goat (n=37) in Korea. The neutralizing antibody (NAb) titers to hAd5 virus were less than 15 in most of samples. Only 8% of goat samples had a NAb titer of 15 or 30. Thus, we showed that hAd5 virus was not neutralized in sera from cattle, pig, and goat, and suggest that the hAd5 vector could be used for the effective delivery of vaccines or proteins in livestock animals in the field.
Adenoviruses, Human*
;
Animals
;
Antibodies, Neutralizing
;
Cattle*
;
Gene Expression
;
Goats*
;
Korea
;
Livestock
;
Republic of Korea*
;
Vaccines
9.Prediction Model for Massive Transfusion in Placenta Previa during Cesarean Section
Jieun KANG ; Hye Sim KIM ; Eun Bi LEE ; Young UH ; Kyoung Hee HAN ; Eun Young PARK ; Hyang Ah LEE ; Dae Ryong KANG ; In Bai CHUNG ; Seong Jin CHOI
Yonsei Medical Journal 2020;61(2):154-160
0.05). The area under the receiver operating characteristics curve (AUC) was 0.922 [95% confidence interval (CI) 0.89–0.95]. In external validation, the discrimination was good, with an AUC value of 0.833 (95% CI 0.70–0.92) for this model. Nomogram calibration plots indicated good agreement between the predicted and observed outcomes, exhibiting close approximation between the predicted and observed probability.CONCLUSION: We constructed a scoring model for predicting massive transfusion during cesarean section in women with placenta previa. This model may help in determining the need to prepare an appropriate amount of blood products and the optimal timing of blood transfusion.]]>
Area Under Curve
;
Blood Transfusion
;
Calibration
;
Cesarean Section
;
Cohort Studies
;
Discrimination (Psychology)
;
Early Intervention (Education)
;
Erythrocytes
;
Female
;
Humans
;
Logistic Models
;
Maternal Age
;
Nomograms
;
Placenta Previa
;
Placenta
;
Placentation
;
Postpartum Hemorrhage
;
Pregnancy
;
ROC Curve
;
Ultrasonography
10.Evaluation of Commercial Immunochromatographic Test Kits for the Detection of Canine Distemper Virus
Dong-Kun YANG ; Ha-Hyun KIM ; Jienny LEE ; Miryeon JI ; Subin OH ; Hyang-Sim LEE ; Bang-Hun HYUN
Journal of Bacteriology and Virology 2020;50(2):117-123
The rapid diagnosis of canine distemper virus (CDV) helps to determine the treatment of dogs in veterinary clinics. We evaluated the performance of seven commercial rapid immunochromatographic test (RICT) kits for the detection of CDV. Six core dog viral pathogens (canine adenovirus type 1 and 2, canine coronavirus, canine parainfluenza virus, canine parvovirus, and rabies virus), five CDV strains (CD1901, Lederle, Rockborn, Onderstepoort, and Synder Hill), and three bacteria (Bordetella bronchiseptica, Leptospira canicola, and Staphylococus aureus) were used to determine the cross-reactivity and detection limits of the kits. The seven commercial RICT kits did not yield positive results with the six dog viruses or the three bacteria. All the RICT kits for CDV detected the Korean CDV isolate. The detection limits of the RICT kits for the Korean CDV isolate, CD1901, belonging to Asia 1 genotype ranged from 103.0 to 104.0 TCID50/mL. There was an average difference of 1.1 in scores judged by eye between four CDV vaccine strains and CD1901 strain. Therefore, the RICT kits enable the detection of CDV vaccine strains, but need to be improved to detect CDV circulating in dog populations in Korea.